CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] (2020)
- Authors:
- USP affiliated authors: SLAVOV, SVETOSLAV NANEV - FMRP ; FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; RODRIGUES, MARIA CAROLINA DE OLIVEIRA - FMRP
- Unidades: FMRP; FCFRP
- DOI: 10.1093/rheumatology/keaa001
- Subjects: CÉLULAS CLONAIS; IMUNOLOGIA; CITOMEGALOVIRUS; TRANSPLANTES; CÉLULAS-TRONCO; RECEPTORES; ANTÍGENOS; VIROLOGIA; TRANSPLANTE AUTÓLOGO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Rheumatology
- ISSN: 1462-0324
- Volume/Número/Paginação/Ano: v. 59, n. 9, p. e38-e40, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ARRUDA, Lucas Coelho Marliére et al. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]. Rheumatology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/rheumatology/keaa001. Acesso em: 23 abr. 2024. , 2020 -
APA
Arruda, L. C. M., Clave, E., Douay, C., Lima Júnior, J. R., Slavov, S. N., Farias, K. C. R. M. de, et al. (2020). CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]. Rheumatology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/rheumatology/keaa001 -
NLM
Arruda LCM, Clave E, Douay C, Lima Júnior JR, Slavov SN, Farias KCRM de, Alberdi AJ, Rodrigues MC de O, Toubert A. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] [Internet]. Rheumatology. 2020 ; 59( 9): e38-e40.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1093/rheumatology/keaa001 -
Vancouver
Arruda LCM, Clave E, Douay C, Lima Júnior JR, Slavov SN, Farias KCRM de, Alberdi AJ, Rodrigues MC de O, Toubert A. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] [Internet]. Rheumatology. 2020 ; 59( 9): e38-e40.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1093/rheumatology/keaa001 - New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
- Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Teplizumab in relatives at risk for type 1 diabetes. [Carta]
- Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II
- Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
- Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers
- Transplante de células-tronco hematopoéticas para doenças auto-imunes graves e refratárias ao tratamento convencional
Informações sobre o DOI: 10.1093/rheumatology/keaa001 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003031464.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
